Dr. Abdool Karim, PhD is a former Principal Investigator with HPTN and a current member of the Executive Committee. She is an infectious diseases epidemiologist and Associate Scientific Director of CAPRISA. Dr. Abdool Karim was Co-Principal Investigator of the CAPRISA 004 trial that demonstrated the efficacy of a topical microbicide, 1% tenofovir gel, for HIV prevention. Dr. Abdool Karim is also Director of the Columbia University-Southern African Fogarty AIDS International Training and Research Programme that has been pivotal in building the science base in southern Africa to enhance responses to the HIV and TB epidemics. She is also an adjunct professor in public health and family medicine at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal and associate professor in clinical epidemiology at Columbia University.